Mobile Menu
Deals & Transactions

Conyers advises on US$350 million privatisation of 3SBio Inc.

June 2013 David Lamb

Conyers Dill & Pearman acted as Cayman counsel to the Buyer Group – 3SBio Chairman and CEO Jing Lou and CITIC Private Equity Funds Management Co. Ltd. in the privatisation of 3SBio Inc. by way of merger. 3SBio shareholders are entitled to $2.38-per-share in cash or US$16.70 per American Depositary Share.

3SBio Inc. is a China-based leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products.

Partner David Lamb based in the Hong Kong office of Conyers Dill & Pearman advised on Cayman law and worked alongside Skadden, Arps, Slate, Meagher & Flom LLP and Akin Gump Strauss Hauer & Feld LLP.

 


David Lamb
Partner

Hong Kong   +852 2842 9511


Accolades
_

"Few firms can come close to Conyers on one critical metric, and this is the breadth of the client base."
- IFLR1000

expertise

Corporate


Related International Offices

Hong Kong


Media Contact

For media enquiries, please contact media@conyersdill.com

Deals & Transactions

Conyers advises on US$350 million privatisation of 3SBio Inc.

14 June 2013 David Lamb

Conyers Dill & Pearman acted as Cayman counsel to the Buyer Group – 3SBio Chairman and CEO Jing Lou and CITIC Private Equity Funds Management Co. Ltd. in the privatisation of 3SBio Inc. by way of merger. 3SBio shareholders are entitled to $2.38-per-share in cash or US$16.70 per American Depositary Share.

3SBio Inc. is a China-based leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products.

Partner David Lamb based in the Hong Kong office of Conyers Dill & Pearman advised on Cayman law and worked alongside Skadden, Arps, Slate, Meagher & Flom LLP and Akin Gump Strauss Hauer & Feld LLP.

 


David Lamb
Partner

Hong Kong   +852 2842 9511


 

expertise

Corporate


International Office(s)

Hong Kong